CH EMED EPR
1.0.0 - trial-use Switzerland flag

This page is part of the FHIR eMedication exchange formats for the implementation effort of CARA within its EPR community (v1.0.0: STU1) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

Example Observation: Observation: Triatec (PML)

Generated Narrative: Observation

Resource Observation "ObservationTriatecPml"

Profile: PML Observation

CH EMED Extension Treatment Plan

url

id

value: id: #urn:uuid:41b97645-e263-47c2-8d96-79da451a33f2

url

externalDocumentId

value: id: #urn:uuid:24c84eef-f9db-4710-8f6c-2d342ad3ac2d

CH EMED Extension MedicationStatement Changed: urn:uuid:41b97645-e263-47c2-8d96-79da451a33f2

CH EMED Extension Pharmaceutical Advice

url

id

value: id: #urn:uuid:41b97645-e263-47c2-8d96-79da451a33f2

url

externalDocumentId

value: id: #urn:uuid:293bf5b1-f663-4914-8080-4e33aa54b909

identifier: id: #urn:uuid:e729b2f6-62aa-4628-8a13-27c8b8674473

status: final

code: CHANGE (IHE Pharmaceutical Advice Status List#CHANGE)

subject: urn:uuid:2dbfe659-07d0-45c7-b8df-4a48372049a3

issued: 11 Apr 2023, 12:00:00

performer: urn:uuid:213d609a-1164-459a-bb10-727516ae3d0c

note: Changed intake to range 0.5-1 tablets after discussion with patient.